September 10, 2026

Helus Pharma CEO to Speak at Morgan Stanley Healthcare Conference

September 9, 2026

Helus Pharma CEO to Speak at H.C. Wainwright Conference Amid Promising Clinical Pipeline

August 28, 2026

New Study Challenges Core Safety Assumption of Electroshock Therapy, CCHR Renews Ban Calls

August 18, 2026

Helus Pharma Strengthens Leadership with Key Appointments as Pipeline Advances

August 14, 2026

Helus Pharma Completes Enrollment in Pivotal Phase 3 Depression Trial, Targets Q4 2026 Data

August 3, 2026

Helus Pharma Appoints Michael Halstead as CEO as Phase 3 Program Advances

July 27, 2026

Website Rental Coaching Expands Local SEO Training to 14 Countries

July 24, 2026

Ireland Bans Electroshock Treatment on Minors, Marking Human Rights Progress